Antonio Garcia Guiñon
Grau: Llicenciat/da
973 705351
agarciag.lleida.ics(ELIMINAR)@gencat.cat
Grups
Publicacions
-
Carrizosa, AM; Beas, F; Gabarrós, M; Acha, P; Torres-Esquius, S; Méndez, J; Landwehr, M; Domingo, A; Mesa, A; Gallur, L; Ortega, M; Zamora, L; Arnan, M; Pomares, H; Tuset, E; Abad, K; Restrepo, J; Fernandez-Serrano, M; Garcia, A; Diaz-Beyá, M; Castaño-Diez, S; Chen, WA; Germing, U; Giagounidis, A; Walter, W; Haferlach, T; Montoro, MJ; Jerez, A; Roue, G; Valcarcel, D; Tutusaus, SS
EZH2 molecular alterations drive micromegakaryocyte expansion in MDS defining a specific high-risk group
Blood 146 2084-2085. .
-
Jiménez-Vicente, C; Beneit, P; Cano-Ferri, I; Merchán, B; Arnan, M; Guiñón, AG; Martinez-Bilbao, C; Alfonso, A; Martínez-Sánchez, P; Alonso-Domínguez, JM; López-Godino, O; Castaño-Díez, S; Zugasti, I; Esteve, J; Díaz-Beyá, M; de la Fuente, A
Enasidenib as treatment for AML with IDH2 mutation: multicenter real-life study of the early-access program in Spain
ANNALS OF HEMATOLOGY 104 4863-4871. .
-
González-Guerrero, L; Castellet, H; Martínez, C; González, N; Guijarro, F; Lloveras, N; Pratcorona, M; Gich, I; Berenguer-Molins, P; Perera-Bel, J; Zamora, L; Mascaró, M; Sampol, A; Garcia-Guiñón, A; Vives, S; Tormo, M; Arnan, M; Villamor, N; Nomdedéu, JF
CD200 in acute myeloid leukemia: marked upregulation in CEBPA biallelic mutated cases
Diagnostic Pathology 20 56-56. .
-
Garcia-Guiñon, A; Charry, PA; Jimenez, M; Sarra, J; Delgado, I; de la Torre, LS; Santaliestra, M; Garcia-Pintos, M; Gonzalez, Y; Senin, A; Motlló, C; Abella, E; Cabezudo, E; Granell, M; Sancho, E; Herranz, MJ; Seres, Y; Gironella, M; Soler, JA; Marti-Tutusaus, JM; Ben Azaiz, R; de Larrea, CF
Real-world evidence of Carfilzomib, Lenalidomide and Dexamethasone (KRD) Scheme in patients with relapsed / refractory multiple myeloma
ANNALS OF HEMATOLOGY 104 1177-1186. .
-
Oñate G; Garrido A; Arnan M; Pomares H; Alonso E; Tormo M; Diaz-Beya M; Vives S; Zamora L; Sampol A; Coll R; Salamero O; Cervera M; Garcia A; Vall-Llovera F; Garcia-Avila S; Bargay J; Ortin X; Iranzo E; Guijarro F; Pratcorona M; Nomdedeu JF; Esteve J; Sierra J
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.
Blood Cancer Journal 15 4-4. .
-
Ribera JM; Morgades M; Garcia-Calduch O; Sirvent M; Buendia B; Cervera M; Luzardo H; Hernandez-Rivas JM; Sitges M; Garcia-Cadenas I; Abrisqueta P; Montesinos P; Bastos-Oreiro M; De Llano MQ; Bravo P; Torrent A; Herrera P; Garcia-Guinon A; Vall-Llovera F; Serrano J; Terol MJ; Bergua JM; Garcia-Noblejas A; Barrenetxea C; Llorente L; Garcia-Belmonte D; Gimeno E; Cladera A; Mercadal S; Sancho JM
Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 109 543-552. .
-
Oñate G; Pratcorona, M; Garrido, A; Artigas-Baleri, A; Bataller, A; Tormo, M; Arnan, M; Vives, S; Coll, R; Salamero, O; Vall-Llovera, F; Sampol, A; Garcia, A; Cervera, M; Avila, SG; Bargay, J; Ortín, X; Nomdedéu, JF; Esteve, J; Sierra, J
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.
Blood Cancer Journal 13 69-69. .
-
Díaz-Santa, J; Rodríguez-Romanos, R; Coll, R; Osca, G; Pratcorona, M; González-Bártulos, M; Garrido, A; Angona, A; Talarn, C; Tormo, M; Arnan, M; Vives, S; Salamero, O; Tuset, E; Lloveras, N; Díez, I; Zamora, L; Bargay, J; Sampol, A; Cruz, D; Vila, J; Sitges, M; Garcia, A; Vall-Llovera, F; Esteve, J; Sierra, J; Gallardo, D
5 '-nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate-risk cytogenetics
EUROPEAN JOURNAL OF HAEMATOLOGY 109 755-764. .
-
Gonzalez J; Jatem E; Roig J; Valtierra N; Ostos E; Abo A; Santacana M; Garcia A; Segarra A
Usefulness of urinary biomarkers to estimate the interstitial fibrosis surface in diabetic nephropathy with normal kidney function.
NEPHROLOGY DIALYSIS TRANSPLANTATION 37 2102-2110. .
-
Villalba, A; Gonzalez-Rodriguez, AP; Arzuaga-Mendez, J; Puig, N; Arnao, M; Arguinano, JM; Jimenez, M; Canet, M; Teruel, A; Sola, M; Díaz, FJ; Encinas, C; Garcia, A; Rosinol, L; Suárez, A; Gonzalez, MS; Izquierdo, I; Hernández, MT; Infante, MS; Sánchez, MJ; Sampol, A; de la Rubia, J
Single versus tandem autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma and high-risk cytogenetics. A retrospective, open-label study of the PETHEMA/Spanish Myeloma Group (GEM)
LEUKEMIA & LYMPHOMA 63 3438-3447. .
-
Moreno, DF; Clapés, V; Soler, JA; González-Montes, Y; Gironella, M; Motlló, C; Granell, M; Abella, E; García-Pintos, M; García-Guiñón, A; Cabezudo, E; Bladé, J; Rosiñol, L
Real-World Evidence of Daratumumab Monotherapy in Relapsed/Refractory Multiple Myeloma Patients and Efficacy on Soft-Tissue Plasmacytomas
Clinical Lymphoma Myeloma & Leukemia 22 635-642. .
-
Encinas, C; Hernandez-Rivas, JA; Oriol, A; Rosinol, L; Blanchard, MJ; Bellón, JM; García-Sanz, R; de la Rubia, J; de la Guía, AL; Jímenez-Ubieto, A; Jarque, I; Inigo, B; Dourdil, V; de Arriba, F; Pérez-Avila, CC; Gonzalez, Y; Hernández, MT; Bargay, J; Granell, M; Rodríguez-Otero, P; Silvent, M; Cabrera, C; Rios, R; Alegre, A; Gironella, M; Gonzalez, MS; Sureda, A; Sampol, A; Ocio, EM; Krsnik, I; García, A; García-Mateo, A; Soler, JA; Martín, J; Arguinano, JM; Mateos, MV; Bladé, J; San-Miguel, JF; Lahuerta, JJ; Martínez-López, J
A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma
Blood Cancer Journal 12 -. .
